1. Home
  2. CVKD vs GIFT Comparison

CVKD vs GIFT Comparison

Compare CVKD & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • GIFT
  • Stock Information
  • Founded
  • CVKD 2022
  • GIFT 1999
  • Country
  • CVKD United States
  • GIFT United States
  • Employees
  • CVKD N/A
  • GIFT N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • GIFT Catalog/Specialty Distribution
  • Sector
  • CVKD Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • CVKD 29.5M
  • GIFT 33.9M
  • IPO Year
  • CVKD 2023
  • GIFT N/A
  • Fundamental
  • Price
  • CVKD $12.64
  • GIFT $1.05
  • Analyst Decision
  • CVKD Strong Buy
  • GIFT Strong Buy
  • Analyst Count
  • CVKD 1
  • GIFT 1
  • Target Price
  • CVKD $32.00
  • GIFT $4.00
  • AVG Volume (30 Days)
  • CVKD 24.4K
  • GIFT 21.6K
  • Earning Date
  • CVKD 11-06-2025
  • GIFT 11-12-2025
  • Dividend Yield
  • CVKD N/A
  • GIFT N/A
  • EPS Growth
  • CVKD N/A
  • GIFT N/A
  • EPS
  • CVKD N/A
  • GIFT N/A
  • Revenue
  • CVKD N/A
  • GIFT $90,569,384.00
  • Revenue This Year
  • CVKD N/A
  • GIFT $5.90
  • Revenue Next Year
  • CVKD N/A
  • GIFT $13.45
  • P/E Ratio
  • CVKD N/A
  • GIFT N/A
  • Revenue Growth
  • CVKD N/A
  • GIFT 8.55
  • 52 Week Low
  • CVKD $8.74
  • GIFT $0.82
  • 52 Week High
  • CVKD $22.90
  • GIFT $3.86
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 48.59
  • GIFT 46.62
  • Support Level
  • CVKD $13.12
  • GIFT $1.04
  • Resistance Level
  • CVKD $13.69
  • GIFT $1.14
  • Average True Range (ATR)
  • CVKD 0.59
  • GIFT 0.08
  • MACD
  • CVKD -0.06
  • GIFT 0.00
  • Stochastic Oscillator
  • CVKD 21.08
  • GIFT 18.10

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: